Literature DB >> 25250917

The validity of self-reported information about hypertensive disorders of pregnancy in a population-based survey: the Tromsø Study.

Marit Falkegård1, Henrik Schirmer, Maja-Lisa Løchen, Pål Øian, Ganesh Acharya.   

Abstract

OBJECTIVE: To investigate the validity of self-reported information about hypertensive disorders in previous pregnancies among women participating in the fourth survey of the Tromsø Study.
DESIGN: Retrospective cohort study with case-control design. POPULATION: Parous women participating in the fourth survey of the Tromsø Study.
METHODS: Medical records including partograms of 200 randomly selected women who had answered positively to whether they had hypertension and/or proteinuria during one or more of their previous pregnancies (cases) and 200 women who had answered negatively (controls) were studied. The cases and controls were matched for age. The investigators were blinded to the allocation of cases and controls until data collection was finished. MAIN OUTCOME MEASURES: Self-reported and actual prevalence of hypertensive pregnancy disorders and predictive value of self-reported hypertension and/or proteinuria in previous pregnancies.
RESULTS: Clinical data were missing for 23.5% (94/400) of the participants (50 cases and 44 controls). A total of 80% (120/150) of cases and 57.1% (89/156) of controls had answered the question on whether or not they had high blood pressure and/or proteinuria during their pregnancies correctly (positive predictive value 0.800; negative predictive value 0.571). The proportion of false-positive cases declined with increasing age while the proportion of false-negative controls increased until 55 years of age.
CONCLUSIONS: We found good concordance between self-reported hypertension and/or proteinuria during previous pregnancies and actual clinical findings among the cases. However, there was a tendency towards under-reporting among controls.
© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Hypertensive disorders of pregnancy; gestational hypertension; preeclampsia; proteinuria; self-reported information; validity

Mesh:

Year:  2014        PMID: 25250917     DOI: 10.1111/aogs.12514

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  Childhood adversities and chronic conditions: examination of mediators, recall bias and age at diagnosis.

Authors:  Mashhood Ahmed Sheikh
Journal:  Int J Public Health       Date:  2017-07-24       Impact factor: 3.380

2.  Women with Adverse Pregnancy Outcomes Have Higher Odds of Midlife Stroke: The Population Assessment of Tobacco and Health Study.

Authors:  Eliza C Miller; Natalie A Bello; Rindcy Davis; Alexander M Friedman; Mitchell S V Elkind; Ronald Wapner; Sarah E Tom
Journal:  J Womens Health (Larchmt)       Date:  2021-11-26       Impact factor: 3.017

3.  Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring.

Authors:  Eileen A Curran; Gerard W O'Keeffe; Ann Marie Looney; Gerard Moloney; Shane V Hegarty; Deirdre M Murray; Ali S Khashan; Louise C Kenny
Journal:  Mol Neurobiol       Date:  2017-10-03       Impact factor: 5.590

4.  The Development of Extremely Preterm Infants Born to Women Who Had Genitourinary Infections During Pregnancy.

Authors:  Alan Leviton; Elizabeth N Allred; Karl C K Kuban; T Michael O'Shea; Nigel Paneth; Andrew B Onderdonk; Raina N Fichorova; Olaf Dammann
Journal:  Am J Epidemiol       Date:  2015-12-13       Impact factor: 4.897

5.  Do self-reported pregnancy complications add to risk evaluation in older women with established cardiovascular disease?

Authors:  Elin Täufer Cederlöf; Nina Johnston; Jerzy Leppert; Pär Hedberg; Bertil Lindahl; Christina Christersson
Journal:  BMC Womens Health       Date:  2019-12-16       Impact factor: 2.809

6.  Pregnancy hypertensive disease and risk of dementia and cardiovascular disease in women aged 65 years or older: a cohort study.

Authors:  M Nelander; S Cnattingius; H Åkerud; J Wikström; N L Pedersen; A-K Wikström
Journal:  BMJ Open       Date:  2016-01-21       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.